Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 223

1.

Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma.

Laursen MB, Falgreen S, Bødker JS, Schmitz A, Kjeldsen MK, Sørensen S, Madsen J, El-Galaly TC, Bøgsted M, Dybkær K, Johnsen HE; Myeloma Stem Cell Network (MSCNET).

Exp Hematol. 2014 Jul 26. pii: S0301-472X(14)00598-0. doi: 10.1016/j.exphem.2014.07.263. [Epub ahead of print] Review.

PMID:
25072621
[PubMed - as supplied by publisher]
2.

The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic.

Bieghs L, Lub S, Fostier K, Maes K, Van Valckenborgh E, Menu E, Johnsen HE, Overgaard MT, Larsson O, Axelson M, Nyegaard M, Schots R, Jernberg-Wiklund H, Vanderkerken K, De Bruyne E.

Oncotarget. 2014 Apr 30. [Epub ahead of print]

PMID:
25008202
[PubMed - as supplied by publisher]
Free Article
3.

Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition.

Falgreen S, Laursen MB, Bødker JS, Kjeldsen MK, Schmitz A, Nyegaard M, Johnsen HE, Dybkær K, Bøgsted M.

BMC Bioinformatics. 2014 Jun 5;15:168. doi: 10.1186/1471-2105-15-168.

PMID:
24902483
[PubMed - in process]
Free PMC Article
4.

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

van de Donk NW, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H, Hajek R, Kleber M, Ludwig H, Morgan G, Musto P, Plesner T, Sezer O, Terpos E, Waage A, Zweegman S, Einsele H, Sonneveld P, Lokhorst HM; European Myeloma Network.

Haematologica. 2014 Jun;99(6):984-96. doi: 10.3324/haematol.2013.100552. Epub 2014 Mar 21.

PMID:
24658815
[PubMed - in process]
Free PMC Article
5.

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

Engelhardt M, Terpos E, Kleber M, Gay F, Wäsch R, Morgan G, Cavo M, van de Donk N, Beilhack A, Bruno B, Johnsen HE, Hajek R, Driessen C, Ludwig H, Beksac M, Boccadoro M, Straka C, Brighen S, Gramatzki M, Larocca A, Lokhorst H, Magarotto V, Morabito F, Dimopoulos MA, Einsele H, Sonneveld P, Palumbo A; European Myeloma Network.

Haematologica. 2014 Feb;99(2):232-42. doi: 10.3324/haematol.2013.099358.

PMID:
24497560
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man.

Bergkvist KS, Nyegaard M, Bøgsted M, Schmitz A, Bødker JS, Rasmussen SM, Perez-Andres M, Falgreen S, Bilgrau AE, Kjeldsen MK, Gaihede M, Nørgaard MA, Bæch J, Grønholdt ML, Jensen FS, Johansen P, Dybkær K, Johnsen HE.

BMC Immunol. 2014 Jan 31;15:3. doi: 10.1186/1471-2172-15-3.

PMID:
24483235
[PubMed - in process]
Free PMC Article
7.

Proof of the concept to use a malignant B cell line drug screen strategy for identification and weight of melphalan resistance genes in multiple myeloma.

Bøgsted M, Bilgrau AE, Wardell CP, Bertsch U, Schmitz A, Bødker JS, Kjeldsen MK, Goldschmidt H, Morgan GJ, Dybkaer K, Johnsen HE.

PLoS One. 2013 Dec 20;8(12):e83252. doi: 10.1371/journal.pone.0083252. eCollection 2013.

PMID:
24376673
[PubMed - in process]
Free PMC Article
8.

Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.

El-Galaly TC, Hutchings M, Mylam KJ, Brown PD, Bukh A, Johnsen HE, Kamper P, Loft A, Iyer V, Gormsen LC, Nielsen AL, Bøgsted M, d'Amore F.

Leuk Lymphoma. 2014 Feb 24. [Epub ahead of print]

PMID:
24354682
[PubMed - as supplied by publisher]
9.

Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy.

Johnsen HE, Bergkvist KS, Schmitz A, Kjeldsen MK, Hansen SM, Gaihede M, Nørgaard MA, Bæch J, Grønholdt ML, Jensen FS, Johansen P, Bødker JS, Bøgsted M, Dybkær K; Myeloma Stem Cell Network (MSCNET).

Leuk Lymphoma. 2014 Jun;55(6):1251-60. doi: 10.3109/10428194.2013.839785. Epub 2013 Nov 1.

PMID:
23998255
[PubMed - in process]
10.

Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation.

Lanza F, Campioni DC, Hellmann A, Milone G, Wahlin A, Walewski J, Spedini P, Fiamenghi C, Cuneo A, Knopińska W, Swierkowska-Czeneszew M, Petriz J, Fruehauf S, Farge D, Mohty M, Passweg J, Ruuto T, Madrigal A, Johnsen HE; Quality Assessment of Haematopoietic Stem Cell Grafting Committee of European Blood and Marrow Transplantation Society.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1670-6. doi: 10.1016/j.bbmt.2013.08.005. Epub 2013 Aug 27.

PMID:
23988403
[PubMed - in process]
11.

Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes.

Dabrowska MJ, Ejegod D, Lassen LB, Johnsen HE, Wabl M, Pedersen FS, Dybkær K.

Leuk Res. 2013 Oct;37(10):1383-90. doi: 10.1016/j.leukres.2013.04.012. Epub 2013 Jul 26.

PMID:
23896059
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/Bioconductor.

Rodrigo-Domingo M, Waagepetersen R, Bødker JS, Falgreen S, Kjeldsen MK, Johnsen HE, Dybkær K, Bøgsted M.

Brief Bioinform. 2013 Apr 29. [Epub ahead of print]

PMID:
23603090
[PubMed - as supplied by publisher]
Free PMC Article
13.

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden.

Blijlevens N, de Château M, Krivan G, Rabitsch W, Szomor A, Pytlik R, Lissmats A, Johnsen HE, de Witte T, Einsele H, Ruutu T, Niederwieser D; CLWP of the EBMT.

Bone Marrow Transplant. 2013 Jul;48(7):966-71. doi: 10.1038/bmt.2012.257. Epub 2012 Dec 17.

PMID:
23241739
[PubMed - indexed for MEDLINE]
14.

Performance comparison of Affymetrix SNP6.0 and cytogenetic 2.7M whole-genome microarrays in complex cancer samples.

Bødker JS, Gyrup C, Johansen P, Schmitz A, Madsen J, Johnsen HE, Bøgsted M, Dybkær K, Nyegaard M.

Cytogenet Genome Res. 2013;139(2):80-7. doi: 10.1159/000345125. Epub 2012 Nov 20.

PMID:
23182917
[PubMed - indexed for MEDLINE]
15.

Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.

El-Galaly TC, d'Amore F, Mylam KJ, de Nully Brown P, Bøgsted M, Bukh A, Specht L, Loft A, Iyer V, Hjorthaug K, Nielsen AL, Christiansen I, Madsen C, Johnsen HE, Hutchings M.

J Clin Oncol. 2012 Dec 20;30(36):4508-14. doi: 10.1200/JCO.2012.42.4036. Epub 2012 Nov 13.

PMID:
23150698
[PubMed - indexed for MEDLINE]
16.

A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells.

Kloster MB, Bilgrau AE, Rodrigo-Domingo M, Bergkvist KS, Schmitz A, Sønderkær M, Bødker JS, Falgreen S, Nyegaard M, Johnsen HE, Nielsen KL, Dybkaer K, Bøgsted M.

BMC Genomics. 2012 Nov 5;13:596. doi: 10.1186/1471-2164-13-596.

PMID:
23127183
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cancer stem cell definitions and terminology: the devil is in the details.

Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, Roesch A, Schuurhuis GJ, Wöhrer S, Arock M, Zuber J, Cerny-Reiterer S, Johnsen HE, Andreeff M, Eaves C.

Nat Rev Cancer. 2012 Nov;12(11):767-75. doi: 10.1038/nrc3368. Epub 2012 Oct 11.

PMID:
23051844
[PubMed - indexed for MEDLINE]
18.

The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practice.

Salar A, Haioun C, Rossi FG, Duehrsen U, Pettengell R, Johnsen HE, Jaeger U, Verhoef G, Schwenkglenks M, Bacon P, Bendall K, Lugtenburg PJ.

Leuk Res. 2012 May;36(5):548-53. doi: 10.1016/j.leukres.2012.02.002. Epub 2012 Mar 3.

PMID:
22385870
[PubMed - indexed for MEDLINE]
19.

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Ross FM, Avet-Loiseau H, Ameye G, Gutiérrez NC, Liebisch P, O'Connor S, Dalva K, Fabris S, Testi AM, Jarosova M, Hodkinson C, Collin A, Kerndrup G, Kuglik P, Ladon D, Bernasconi P, Maes B, Zemanova Z, Michalova K, Michau L, Neben K, Hermansen NE, Rack K, Rocci A, Protheroe R, Chiecchio L, Poirel HA, Sonneveld P, Nyegaard M, Johnsen HE; European Myeloma Network.

Haematologica. 2012 Aug;97(8):1272-7. Epub 2012 Feb 27.

PMID:
22371180
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.

Hoffmann MH, Klausen TW, Boegsted M, Larsen SF, Schmitz A, Leinoe EB, Schmiegelow K, Hasle H, Bergmann OJ, Sorensen S, Nyegaard M, Dybkaer K, Johnsen HE.

Cytometry B Clin Cytom. 2012 May;82(3):123-31. doi: 10.1002/cyto.b.20633. Epub 2012 Feb 10.

PMID:
22328535
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk